The human glioblastoma cells were treated with 15 μM WIN55,212-2 (CB1/CB2 agonist) or its inactive enantiomer, or 10 μM JWH133 (CB2-selective agonist) (Figure 2). Here, CNR2 is linked to glioblastoma.